LATANOPROST/TIMOLOL GPPL 50/5 latanoprost 50 microgram/mL and timolol 5 mg/mL (as maleate) eye drops solution bottle

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

timolol maleate, Quantity: 6.83 mg/mL (Equivalent: timolol, Qty 5 mg/mL); latanoprost, Quantity: 0.05 mg/mL

Disponível em:

Arrotex Pharmaceuticals Pty Ltd

DCI (Denominação Comum Internacional):

Latanoprost,Timolol maleate

Forma farmacêutica:

Eye Drops, solution

Composição:

Excipient Ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride

Via de administração:

Ophthalmic

Unidades em pacote:

1 x 2.5 mL, 3 x 2.5 mL

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. Latanoprost/timolol (50 microgram/mL/5 mg/mL) eye drops should not be used to initiate therapy.

Resumo do produto:

Visual Identification: Clear, colourless liquid.; Container Type: Bottle; Container Material: LDPE; Container Life Time: 21 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2017-03-20